EWTX270319C00035000
EWTX Mar 19 2027 35.00 Call
optionOPRA
InactiveSep 11, 2026
13.00USD-5.317%(-0.73)1Vol4OI
Loading…
Underlying
Underlying Price
$39.57
Type
Call
Strike
35
Expiration
Mar 19, 2027
DTE
163d
Moneyness
ITM
Intrinsic
$4.57
EWTX 35 Call Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Oct 16, 2026 | 9d | — | — | 0 | 0 |
| Nov 20, 2026 | 44d | $8.30 | -25.23% | 1 | 2 |
| Dec 18, 2026 | 72d | — | — | 0 | 0 |
| Jan 15, 2027 | 100d | — | — | 0 | 0 |
| Feb 19, 2027 | 135d | — | — | 0 | 0 |
| Mar 19, 2027 | 163d | $13.00 | -5.32% | 1 | 4 |
| May 21, 2027 | 226d | — | — | 0 | 0 |
EWTX Profile
edgewise therapeutics is a biotechnology company focused on developing novel therapies for diseases involving skeletal muscle. the company is headquartered in boulder, co and received its series a financing from orbimed.